IL94082A0 - 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them - Google Patents
3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL94082A0 IL94082A0 IL94082A IL9408290A IL94082A0 IL 94082 A0 IL94082 A0 IL 94082A0 IL 94082 A IL94082 A IL 94082A IL 9408290 A IL9408290 A IL 9408290A IL 94082 A0 IL94082 A0 IL 94082A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- substituted carbamoyl
- indole derivatives
- Prior art date
Links
- VFHUJFBEFDVZPJ-UHFFFAOYSA-N 1h-indole-2-carboxamide Chemical class C1=CC=C2NC(C(=O)N)=CC2=C1 VFHUJFBEFDVZPJ-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL8900963 | 1989-04-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL94082A0 true IL94082A0 (en) | 1991-01-31 |
Family
ID=19854496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL94082A IL94082A0 (en) | 1989-04-18 | 1990-04-13 | 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5102901A (fr) |
| EP (1) | EP0393766A3 (fr) |
| JP (1) | JPH02292281A (fr) |
| AU (1) | AU634534B2 (fr) |
| CA (1) | CA2014641A1 (fr) |
| IL (1) | IL94082A0 (fr) |
| NZ (1) | NZ233285A (fr) |
| ZA (1) | ZA902794B (fr) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8814277D0 (en) * | 1988-06-16 | 1988-07-20 | Glaxo Group Ltd | Chemical compounds |
| EP0375045A1 (fr) * | 1988-12-22 | 1990-06-27 | Duphar International Research B.V | Dérivés d'indoles annelés |
| US4916129A (en) * | 1989-01-19 | 1990-04-10 | E. I. Du Pont De Nemours And Company | Combination β-blocking/angiotensin II blocking antihypertensives |
| GB8913646D0 (en) * | 1989-06-14 | 1989-08-02 | Glaxo Group Ltd | Chemical compounds |
| HU211081B (en) * | 1990-12-18 | 1995-10-30 | Sandoz Ag | Process for producing indole derivatives as serotonin antagonists and pharmaceutical compositions containing the same |
| US6069162A (en) * | 1996-05-27 | 2000-05-30 | Fujisawa Pharmaceutical Co., Ltd. | Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| WO2002041889A2 (fr) * | 2000-11-24 | 2002-05-30 | Smithkline Beecham P.L.C. | Composes utiles pour le traitement de troubles du snc |
| BR0212676A (pt) * | 2001-09-21 | 2006-05-23 | Upjohn Co | compostos terapêuticos ligantes de 5-ht, composições farmacêuticas compreendendo tais compostos e seus usos |
| WO2005058327A1 (fr) | 2003-12-17 | 2005-06-30 | Akzo Nobel N.V. | Derives tricycliques de piperazine 1-[(3-indol-3-yl)carbonyl] utiles en tant qu’agonistes du recepteur cannabinoide cb1 |
| DE102004025000A1 (de) * | 2004-05-21 | 2005-12-08 | Bayer Technology Services Gmbh | Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie |
| CN101460458A (zh) | 2006-02-15 | 2009-06-17 | 阿勒根公司 | 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物 |
| US8097644B2 (en) * | 2006-03-28 | 2012-01-17 | Allergan, Inc. | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist |
| US8524917B2 (en) * | 2007-01-11 | 2013-09-03 | Allergan, Inc. | 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity |
| MX2009007334A (es) | 2007-01-11 | 2009-07-15 | Allergan Inc | Compuestos de amida del acido indol-3-carboxilico 6-substituido que tienen actividad antagonista biologica del receptor esfingosina-1-fosfato (s1p). |
| BRPI0817397A2 (pt) * | 2007-09-24 | 2015-04-07 | Allergan Inc | Compostos indol contendo grupos arila ou heteroarila com atividade biológica do receptor de esfingosina-1-fosfato (sip) |
| US8143291B2 (en) | 2008-05-09 | 2012-03-27 | Allergan, Inc. | Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity |
| EP2328863A1 (fr) * | 2008-08-12 | 2011-06-08 | Allergan, Inc. | Antagonistes des récepteurs de la sphingosine-1-phosphate (s1p) et leurs procédés d'utilisation |
| WO2011008475A1 (fr) | 2009-06-30 | 2011-01-20 | Allergan, Inc. | Composés de 2-(arylméthyl, aryloxy ou arylthio)-n-pyridin-2-yl-arylacétamide ou de 2,2-bis(aryl)-n-pyridin-2-yl-acétamide éventuellement substitués comme médicaments pour le traitement de maladies des yeux |
| US8168795B2 (en) | 2009-08-11 | 2012-05-01 | Allergan, Inc. | Selective sphingosine-1-phosphate receptor antagonists |
| WO2011028927A1 (fr) | 2009-09-04 | 2011-03-10 | Allergan, Inc. | Antagonistes sélectifs des récepteurs de sphingosine-1-phosphate |
| CA2775587A1 (fr) | 2009-09-29 | 2011-04-07 | Allergan, Inc. | Composes pyridines a noyaux condenses comme modulateurs selectifs d'un sous-type des recepteurs de la sphingosine-1-phosphate-2 (s1p2) |
| US8741875B2 (en) | 2009-11-24 | 2014-06-03 | Allergan, Inc. | Compounds as receptor modulators with therapeutic utility |
| MX2012006028A (es) | 2009-11-24 | 2012-06-19 | Allergan Inc | Compuestos novedosos como moduladores de receptor con utilidad terapeutica. |
| WO2011082266A2 (fr) | 2009-12-30 | 2011-07-07 | Arqule, Inc. | Composés hétérocycliques substitués |
| BR112013012719A2 (pt) | 2010-11-22 | 2019-09-24 | Allergan Inc | "compostos como moduladores de receptor com utilidade terapêutica". |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4691016A (en) * | 1981-11-06 | 1987-09-01 | Riker Laboratories, Inc. | Intermediates for the preparation of 8,9-dihalobenzo[ij]quinolizine carboxylic acids |
| US4808581A (en) * | 1986-03-17 | 1989-02-28 | Glaxo Group Limited | Imidazolyl- indolylpropanones as 5-HT3 receptor antagonists |
| DE3885357T2 (de) * | 1987-06-29 | 1994-03-24 | Duphar Int Res | Anellierte Indolderivate. |
| EP0306323B1 (fr) * | 1987-09-03 | 1994-09-21 | Glaxo Group Limited | Dérivés de lactames |
| GB8720693D0 (en) * | 1987-09-03 | 1987-10-07 | Glaxo Group Ltd | Chemical compounds |
| GB8723157D0 (en) * | 1987-10-02 | 1987-11-04 | Beecham Group Plc | Compounds |
| GB8802127D0 (en) * | 1988-02-01 | 1988-03-02 | Glaxo Group Ltd | Chemical compounds |
| GB8814277D0 (en) * | 1988-06-16 | 1988-07-20 | Glaxo Group Ltd | Chemical compounds |
| EP0350130A3 (fr) * | 1988-07-07 | 1991-07-10 | Duphar International Research B.V | 1H-indazoles 1,7-annelés substitués |
| GB8913646D0 (en) * | 1989-06-14 | 1989-08-02 | Glaxo Group Ltd | Chemical compounds |
-
1990
- 1990-04-11 ZA ZA902794A patent/ZA902794B/xx unknown
- 1990-04-11 NZ NZ233285A patent/NZ233285A/en unknown
- 1990-04-12 EP EP19900200908 patent/EP0393766A3/fr not_active Withdrawn
- 1990-04-13 IL IL94082A patent/IL94082A0/xx unknown
- 1990-04-13 US US07/508,420 patent/US5102901A/en not_active Expired - Fee Related
- 1990-04-17 JP JP2099504A patent/JPH02292281A/ja active Pending
- 1990-04-17 AU AU53614/90A patent/AU634534B2/en not_active Ceased
- 1990-04-17 CA CA002014641A patent/CA2014641A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US5102901A (en) | 1992-04-07 |
| CA2014641A1 (fr) | 1990-10-18 |
| ZA902794B (en) | 1991-04-24 |
| JPH02292281A (ja) | 1990-12-03 |
| EP0393766A3 (fr) | 1991-11-06 |
| NZ233285A (en) | 1992-06-25 |
| AU5361490A (en) | 1990-10-25 |
| AU634534B2 (en) | 1993-02-25 |
| EP0393766A2 (fr) | 1990-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL95045A0 (en) | Thienodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91129A0 (en) | Aminomethyloxooxazolidinyl arylbenzene derivatives,their preparation and pharmaceutical compositions containing them | |
| IL90245A0 (en) | Ethenediamine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL95155A0 (en) | 1h-indazole-3-carboxamides,their preparation and pharmaceutical compositions containing them | |
| IL95640A0 (en) | 1-cycloalkylpiperidines,their preparation and pharmaceutical compositions containing them | |
| IL99225A0 (en) | 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL96385A0 (en) | Indole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL96516A0 (en) | Benzofuran derivatives,their preparation and pharmaceutical compositions containing them | |
| IL100262A0 (en) | Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL94556A0 (en) | Hydroxypropylamines,their preparation and pharmaceutical compositions containing them | |
| IL94082A0 (en) | 3-n-substituted carbamoyl-indole derivatives,their preparation and pharmaceutical compositions containing them | |
| IL97050A0 (en) | 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation | |
| IL98542A0 (en) | Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL93124A0 (en) | Benzocycloalkenyldihydroxyalkanoic-acid derivatives,their preparation and pharmaceutical compositions | |
| IL88989A (en) | 16-dehydro-vitamin d3 derivatives, their preparation and pharmaceutical compositions containing them | |
| IL96384A0 (en) | Pyridazine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL92710A0 (en) | 2-iminobenzothiazoline derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91245A0 (en) | Benzopyranol derivatives,their preparation and pharmaceutical compositions containing them | |
| IL90002A0 (en) | Phosphonoalkylpurine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL91709A0 (en) | Substituted thienopyrans,their preparation and pharmaceutical compositions containing them | |
| IL92326A0 (en) | Substituted oxadiamino-butanes,their preparation and pharmaceutical compositions containing them | |
| IL96252A0 (en) | Pyridine derivatives,their preparation and pharmaceutical compositions containing them | |
| IL97918A0 (en) | Serotonin-antagonist naphthosultam derivatives,their preparation and pharmaceutical compositions containing them | |
| IL96216A0 (en) | Peptide derivatives,their preparation and pharmaceutical compositions containing them | |
| IL93750A0 (en) | Tetrahydronaphthalene derivatives,their preparation and pharmaceutical compositions containing them |